Results 91 to 100 of about 252 (105)

Positive effects of the traditional Chinese medicine MLC901 in cognitive tasks. [PDF]

J Neurosci Res, 2015
Lorivel T, Gandin C, Veyssière J, Lazdunski M, Heurteaux C.   +4 more
europepmc   +1 more source

The NeuroAiD Safe Treatment (NeST) Registry: a protocol. [PDF]

BMJ Open, 2015
Venketasubramanian N, Kumar R, Soertidewi L, Abu Bakar A, Laik C, Gan R.   +5 more
europepmc   +1 more source

Traditional Chinese medicine for cardiovascular disease: efficacy and safety. [PDF]

Front Cardiovasc Med
Lin Y, Han Y, Wang Y.
europepmc   +1 more source

Assessment of the reporting quality of RCTs for donepezil in Alzheimer published from 2008 to 2024 using the CONSORT statement [PDF]

Δρόσος, Απόστολος Α., Δρόσος, Απόστολος Α.   +1 more
core  

Spinal Cord Injury-Assessing Tolerability and Use of Combined Rehabilitation and NeuroAiD (SATURN Study): Protocol of An Exploratory Study In Assessing the Safety and Efficacy of NeuroAiD Amongst People Who Sustain Severe Spinal Cord Injury.

JMIR Res Protoc, 2016
Kumar R, Htwe O, Baharudin A, Ariffin MH, Abdul Rhani S, Ibrahim K, Rustam A, Gan R.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

A Long-term Study of NeuroAid (MLC601, MLC901) in Patients with Alzheimer's Disease; An Extension 8-year Follow-up Study

Current Aging Science, 2023
Background: MLC601 and MLC901 showed neuroprotective and neuroregenerative properties and positive results in the treatment of dementia and cognitive impairment. This study aimed to investigate the long-term benefits of monotherapy with MLC601 and MLC901 in patients with Alzheimer's disease (AD).
Hossein, Pakdaman, Ali, Amini Harandi, Koroush, Gharagozli, Fatemeh, Siavoshi, Siavash, Shirzadeh Barough, Ehsan, Sharifipour, Akram, Esfandani, Saba, Ilkhani, Fatemeh Sadat, Tabatabaei, Seyed Ali, Sobhanian   +9 more
openaire   +2 more sources

Neuroprotective and neuroproliferative activities of NeuroAid (MLC601, MLC901), a Chinese medicine, in vitro and in vivo

Neuropharmacology, 2010
Although stroke remains a leading cause of death and adult disability, numerous recent failures in clinical stroke trials have led to some pessimism in the field. Interestingly, NeuroAid (MLC601), a traditional medicine, particularly used in China, South East Asia and Middle East has been reported to have beneficial effects in patients, particularly in
Heurteaux, C., Gandin, C., Borsotto, M., Widmann, C., Brau, F., Lhuillier, M., Onteniente, Brigitte, Lazdunski, Michel   +7 more
openaire   +3 more sources